Overview

Frankman Group is headquartered in Suzhou, China and is a global medical conglomerate with six independent and strategically affiliated business companies. Its products cover surgical instruments (including intelligent surgical platforms and energy platforms), endoscopic diagnostic and therapeutic instruments, endoscopic imaging equipment and instruments, and other fields. The group company has obtained multiple certifications such as SFDA, FDA, ISO13485, CE, KFDA, ANVISA, etc., and has been rated as an "excellent high-tech enterprise" for many consecutive years. The first phase of the group headquarters has a construction area of over 40000 square meters, including nearly 15000 square meters of 100000 level clean rooms. It also has various professional laboratories and a professional medical animal experimental center, and the product technology and clinical technology achieved have been verified by international standards. The sales of products under the group have covered more than 1000 hospitals in China, and are also sold to more than 50 countries and regions around the world such as Asia, Europe, South America, Africa, etc. The strong academic support has been highly recognized by doctors and experts at home and abroad. In 2015, as a globally leading Boston Scientific Medical Company, Frankman made a strategic investment and became one of its shareholders, confirming Frankman's achievements in the development process. The two sides quickly launched in-depth cooperation in research and development, production, sales and other fields, including jointly building an internationally leading endoscopy professional education and training center. In the future, Frankman will join hands with Boston Scientific to uphold and practice the mission of "putting patients first, miracles will happen", and strive to become an innovative, professional, and respected international company in the medical field. 法兰克曼集团总部位于中国苏州，是一家全球型医疗集团，拥有六个独立运营、战略关联的业务公司，产品覆盖外科手术器械（包括智能外科平台及能量平台）、内镜系列诊断和治疗器械、内窥镜成像设备和器械等领域。集团公司先后获得 SFDA、FDA、ISO13485、CE、KFDA、ANVISA 等多项认证，并连续多年被评为“优秀高新技术企业”。 集团总部一期建筑面积 4 万余平方米，其中十万级洁净间近 1.5 万平方米，同时具有各类专业实验室以及专业的医学动物实验中心，实现的产品技术与临床技术均经过国际标准验证。集团旗下产品销售已涵盖国内 1000 多家医院，同时销往亚洲、欧洲、南美洲、非洲等全球五十多个国家和地区，强大的学术支持得到了国内外医生和专家的高度认可。 2015 年，作为全球领先的美国波士顿科学医疗公司战略投资法兰克曼并成为股东之一，证实了法兰克曼在发展过程中取得的成就。双方快速在研发、生产、销售等领域展开深入合作，包括共建了国际领先的内镜专业教育培训中心。 未来，法兰克曼将携手波士顿科学，秉承和践行“将患者放在首位，奇迹就会发生”的使命，致力于成为一家创新、专业并受医疗领域尊重的国际化公司。